Summary. The mechanism by which a horse conceptus-derived immunosuppressive factor (HCS) of Mr > 100 000 inhibits lymphocyte proliferation was investigated. The factor was obtained from the culture supernatants of 20-day-old horse conceptuses; activity, identified by reduced uptake of [3H]thymidine by mitogen-stimulated lymphocytes, was greatest (P < 0\m=.\01) in cultures stimulated by mitogen from pokeweed. HCS also suppressed cell proliferation stimulated by phytohaemagglutinin (P < 0\m=.\01), but had no effect on lipopolysaccharide-stimulated cells (P > 0\m=.\05). Data from a fluorescence\x=req-\ activated cell sorter indicated that supplementation with HCS reduced the number of T cells in phytohaemagglutinin-stimulated cultures and suppressed proliferation of T and B cells in pokeweed-mitogen-stimulated cultures compared with controls. Cell proliferation was greater (P < 0\m=.\01) in cultures supplemented with HCS 24 h after stimulation than in those treated at the start of stimulation, and was even greater (P < 0\m=.\01) when cells were treated 48 h after stimulation. The removal of HCS from treated lymphocyte cultures resulted in complete recovery of cell responsiveness, and stimulated proliferation of treated cells did not differ (P > 0\m=.\05) from that of control cells. The addition of stimulated equine lymphocyte supernatant to cultures supplemented with HCS did not significantly increase (P > 0\m=.\05) cell proliferation in response to pokeweed mitogen.
Introduction
A 30 000 kDa factor in medium conditioned by horse conceptuses has shown immunosuppressive activity (Roth et al, 1990) . Roth et al. (1991) conceptus-derived immunosuppressive factor (HCS) has M, > 100 000. High Mr components of cultures of conceptuses and of gravid uterine fluid of other domestic species, such as cows (Segerson & Bazer, 1989) , sheep Murray et al, 1987) and pigs (Murray et al, 1987) , also suppress lymphocytes when used to supplement blastogenesis cultures in vitro. These suppressive factors may play a role in protecting the conceptus from maternal immunological attack during pregnancy. In horses, one such role may be to aid the temporary protection of the endometrial cups, which, although surrounded by lymphocytes, are not destroyed until day 120 of pregnancy (Allen, 1979) . Most investigations have been directed towards identifying and characterizing uterine and conceptus-derived factors (Murray et al, 1978; Godkin et al, 1982; Hansen et al, 1987; Newton et al, 1988; McDowell et al, 1990) , but their functional significance is largely unknown.
Immunosuppressive mechanisms of components obtained from uterine fluid or conceptus tissue has been reported for humans (Pockley & Bolton, 1990; Saito et al, 1990) , mice (Clark et al, 1985; Mayumi et al, 1985; Clark et al, 1986) , sheep (Segerson, 1988) and, more recently, cows (Segerson & Libby, 1990 (Sharon, 1983) , but in most immunosuppressive studies only phytohaemagglutinin, a potent T-cell activator, has been used to stimulate lymphocyte proliferation. Because cell-mediated immunity is of greater concern than humoral immunity in fetal allograft acceptance, cells have been the focus of most attempts to elucidate suppressor factor mechan¬ isms. The production of interleukin 2 (IL-2) and the expression of the high-affinity IL-2 receptor (IL-2R) are critical for proliferation of cells in response to either phytohaemagglutinin or antigen (Depper et al, 1984) . Data from several experiments indicate that IL-2 production, IL-2R expression and their interaction are disrupted by conceptus-or uterine-derived suppressor factors in many species, including mice (Clark et al, 1985 (Clark et al, , 1986 , humans (Saito et al, 1990 ; Menu & Chaouat, 1989) , sheep (Segerson, 1988) and cows (Segerson & Gunsett, 1990; Segerson & Libby, 1990) .
Although results from mitogen-stimulated lymphocyte proliferation assays have provided valu¬ able information about the response of these cells to immunosuppressive factors in vitro, the responses of specific cell subsets have not been determined. Antibodies to unique cell subset anti¬ gens (CD4, CD5 and CD8) are available for labelling selective cell populations. Antibodies to equine lymphocytes bind either the entire T-cell population or a subset of suppressor cells (Wyatt et al, 1988) . Specific fluorescent antibody labelling followed by fluorescence-activated cell sorter (FACS) analysis provides an accurate method for immunophenotypically distinguishing and quantifying cell subsets in a mixed cell population (Jackson & Warner, 1986) .
The experiments described were designed (i) to examine the effect of HCS on and cells using various mitogens and FACS analysis; (ii) to determine the temporal relationship of HCS activity and lymphocyte activation and (iii) to define the proposed IL-2 associated mechanism of lymphocyte suppression more clearly.
Materials and Methods

Animals and conceptus cultures
The horse breeding regimen and conceptus collection techniques were as described by Roth et ai (1990) . Briefly, conceptuses were collected by non-surgical uterine flushing on day 20 (ovulation on day 0) using sterile phosphatebuffered saline (PBS) supplemented with either 1% calf serum (Hyclone, Logan, UT) and 1% antibiotic/antimycotic (group 1), or only 1% antibiotic/antimycotic (group 2). Under sterile conditions, conceptuses were rinsed twice in their respective medium, after which group 1 conceptuses were rinsed once in RPMI-1640 (Gibco, Grand Island, NY) supplemented with 15% fetal calf serum (FCS; Hyclone, Logan, UT; non-heat-treated, <0T ng ml"1 endotoxin) and 1% antibiotic/antimycotic (RPMI + ), and group 2 conceptuses were rinsed in RPMI-1640 with 1% antibiotic/ antimycotic (RPMI) . The three group 1 conceptuses were each placed in a 50 ml tissue culture flask containing 20 ml RMPI +. Cutlures were incubated for 48 h at 37°C in a humidified atmosphere of 5% C02 in air. The three group 2 conceptuses were each placed in a 50 ml tissue culture flask containing 15 ml RPMI and were incubated for 30 h under the same conditions described for group 1. Conceptus culture supernatants from each group were pooled (HCS 1 and HCS 2), centrifuged (600 g for 20 min), filtered (0-2 µ ) and stored in aliquots at -80°C. A lymphocyte proliferation assay was used to determine that there was no difference (P > 0-05) in suppressive activity between HCS 1 and HCS 2. Supplementation with equine lymphocyte supernatant Equine peripheral blood lymphocyte supernatant was generated by combining peripheral blood lymphocytes from three mares, diluting cells in RPMI+ to a concentration of 5 106 ml"1 (10 ml total), adding 100µg phyto¬ haemagglutinin, incubating for 6 h at 37°C and centrifuging at 400 g for 10 min. The cells were resuspended in 10 ml fresh RPMI + , incubated for 18 h and again centrifuged at 600 # for 10 min to obtain peripheral blood lymphocyte supernatant. Control medium (CM) consisted of 10 ml of the same RPMI + incubated for 18 h. The peripheral blood lymphocyte supernatant assay was prepared with three lymphocyte populations. Two 96-well plates were set up with serial dilutions of HCS 2 (10-0-625 µ per well). Cells were added to wells (1 10s per well), and pokeweed mitogen was added to all wells except the non-stimulated controls. All wells of one plate received 50 µ peripheral blood lymphocyte supernatant, whereas all wells of the second plate received 50 µ CM. After 24 h of culture, all wells received another 40 µ of their respective medium, bringing the total well volume to 150 µ and the assay was completed as previously described.
Supplementation with IL-2
Because recombinant human interleukin-2 (rIL-2) will interact with horse IL-2R (Fenwick et ai, 1988) , rIL-2 (Cetus Corp., Emeryville, CA) was used in two assays designed to determine whether supplementation of IL-2 to HCS-treated lymphocytes would override the suppressive effect of HCS. Peripheral blood lymphocytes from three mares were used. In the first experiment, two sets of quadruplicate wells of each peripheral blood lymphocyte popu¬ lation were supplemented with 3, 6, 12 and 24 µ of HCS 1. One set of each quadruplicate pair also received rIL-2 (200 U ml" ). Suboptimal phytohaemagglutinin was added to all wells.
In the second experiment, HCS 2 was added to cultures at 15% of well volume and cell proliferation was stimu¬ lated with the suboptimal dose of phytohaemagglutinin. Serial dilutions of rIL-2 (50-0-78 U ml" !) were also added to cultures. Non-stimulated cells were supplemented with rIL-2 as controls. The positive control consisted of cells, phytohaemagglutinin and rIL-2, but no HCS.
IL-2-dependent murine cytolytic T-lymphocyte cell line (CTLL-2 cells).
Unlike resting lymphocytes, CTLL-2 cells continuously express the high-affinity IL-2R complex and the addition of small concentrations of IL-2 will immediately stimulate these cells to proliferate, whereas a deficiency of IL-2 will lead to their rapid demise (Gillis et ai, 1978 (Luginbuhl et ai, 1985) . All main effect interactions were tested (i.e. treatment or time HCS or rIL-2 dose). Between-treatment groups and within treatment differences were determined by Tukey mean comparison tests. The effects of rIL-2 on HCS-treated cells and untreated cells were compared by carrying out regression analysis with data in each of the two rIL-2 supplementation assays. Treatment curves were compared and tested for differences in intercepts, linear functions and quadratic functions, and insignificant terms were dropped from the model.
Results
Mitogen comparison
The effect of HCS on lymphocyte cultures differed (P < 0-01) depending on the mitogen used to stimulate lymphocyte proliferation (Table 1) . The results of a 3 6 factorial arrangement anova and Tukey mean comparisons showed that, compared with stimulated controls, the percentage suppression of HCS-treated cell proliferation was greater (P < 001) in pokeweed-mitogenstimulated cultures than in lipopolysaccharide-and phytohaemagglutinin-stimulated cultures. Phytohaemagglutinin-stimulated cells were suppressed (P < 0-01) by high concentrations of HCS (10 and 20 µ per well), but lipopolysaccharide-stimulated cells were unaffected (P > 005) at all concentrations of HCS (within mitogen Tukey mean comparisons). Non-stimulated control values were significantly greater in the phytohaemagglutinin and pokeweed stimulated assays, probably owing to vaccines received by the horses 1 week before lymphocyte collection. Lymphocytes treated with HCS 2 could respond maximally to pokeweed mitogen stimulation (Fig. 2) Equine cell supernatant and IL-2 supplementation Phytohaemagglutinin-stimulated peripheral blood lymphocyte supernatant was added to HCS 2-treated equine lymphocytes in an attempt to augment their proliferative response to pokeweed mitogen, but compared with proliferation in control medium-supplemented cultures, there was no difference (P > 005) in suppressive effect of HCS 2. The addition of an extremely high concen¬ tration of rIL-2 (200 U ml"1) to HCS 1-treated cells did not override the suppressive activity of HCS 1. Although proliferation in cultures supplemented with rIL-2 was greater (P < 001) than that in cultures without rIL-2, a dose-dependent decrease in proliferation with the addition of HCS was observed even in cultures with 200 U ml"1 rIL-2 (P < 001). Furthermore, results from the regression analysis showed that both treatment curves were linear with the same slope (P > 005; ANOR; y = 86-37-2-92*; R2 = 0-84) and only the intercepts were different (P < 0-01). Similarly, regression analysis was used to determine that the slopes of the two treatment curves, phyto¬ haemagglutinin and phytohaemagglutinin + HCS, were linear and did not differ ( > 005) (Fig. 3) . Again, only the intercepts were different (P < 001). The results of the 3x7 factorial anova and Tukey mean comparisons showed that overall proliferation in HCS 2-treated cultures was less (P < 001) than that in phytohaemagglutinin control cultures, but greater (P < 001) than that in nonstimulated cultures. Whereas the intercepts of all three treatment curves differ (P < 0-01), the linear slopes of the phytohaemagglutinin and phytohaemagglutinin plus HCS 2 curves are the same (P > 0-05; ANOR; R2 = 0-84).
CTLL-2 cells and murine splenocytes CTLL-2 cell proliferation in response to exogenous rIL-2 was not affected by the addition of the Mr> 100 000 fraction of HCS, or the two fractions of CM (Table 2) . However, the MT < 100 000 fraction of HCS did inhibit CTLL-2 proliferation (P < 001). While there was no effect of rIL-2 concentration (P > 005) except in the standard dose response, only in the standard did a decrease in rIL-2 result in a significant decrease in cell proliferation (P < 005). HCS appeared to be effective in suppressing pokeweed-mitogen-stimulated murine splenocytes as incorporation of [3H]thymidine was less (P < 001) in cultures treated with the Mx > 100 000 HCS fraction than that in cultures treated with the Mr > 100 000 CM fraction. However, there were no differences in proliferation between treatments with concanavalin A or phytohaemagglutinin (P > 005).
FACS analysis
Because of the 96 h culture period before cell labelling and fixing, the cell concentration in each flask differed from the initial 1 106 ml"l: there was a decrease in cell number in the control flask and an increase in the mitogen-stimulated flasks. For this reason, the data are presented as final cell numbers ml"1. Relative to non-stimulated controls, there was an increase in total cells with both phytohaemagglutinin and pokeweed mitogen stimulation ( + 36 000 and + 11 000 cells ml" ', respectively) (Table 3) . However, a more exaggerated increase in cells was observed with both mitogens ( + 238 000 and +236000cells ml"1, respectively). The addition of HCS to phyto¬ haemagglutinin-stimulated cells resulted in a decrease of 66 000 and 20 000 cells ml-1 compared with phytohaemagglutinin-stimulated cells without HCS. When HCS was added to pokeweed mitogen-stimulated cells, a decrease in cells also occurred (-19 000 cells ml" ·) and an (Fig. 4) . Compared with phytohaemagglutinin-and pokeweed mitogenstimulated controls, the average percentage of blast cells in HCS-treated cultures decreased from 42-8 to 25-8% and from 42-2 to 8-9%, respectively. Values represent average number of antibody-labelled cells ml"1 + sem (x 10"3) for two lymphocyte populations and the average change in cell number compared with the control. "Culture treatments are: Control -no mitogen or HCS; phytohaemagglutinin = phytohaemagglutinin-stimulated; phytohaemagglutinin + = phytohaemagglutinin-stimulated and HCS-2-treated; pokeweed = pokeweed mitogenstimulated; Pokeweed + = pokeweed mitogen-stimulated and HCS-2-treated. Lala, 1979; Jenkinson & Owen, 1980; Billington & Burrows, 1986; Zuckerman & Head, 1986; Allen et al, 1987 (Beer et al, 1975 ). An immunosuppressive substance (HCS) produced by the horse conceptus and acting on cells may inhibit the T-cell response to fetal antigens, thereby interfering with the otherwise eminent allograft rejection response. Maternal systemic immune responses would be unaffected by the localized activity of HCS, which may explain why the immune function of pregnant females is not compromised and anti-fetal antibodies are found in maternal circulation of 90% of normal equine pregnancies (Allen et al, 1987 ), yet the conceptus remains unharmed.
Through the use of phytohaemagglutinin, a potent T-cell stimulator, pokeweed mitogen, a Tcell-dependent B-cell stimulator and lipopolysaccharide, a T-cell-independent B-cell stimulator (Sharon, 1983; Jelinek & Lipsky, 1987) (Howard & Paul, 1983) and since pokeweed mitogen is a weak T-cell stimulator, the absence of even a small portion of cells may have resulted in deficient lymphokine production and a severe reduction of B-cell proliferation. The (Altman, 1990) , these results indicate that HCS interferes with the initial steps of cell activation and does not affect the later events involved in proliferation. Postponing HCS treatment for 24 h appeared to allow the cells enough time to become activated by mitogen and to begin producing lymphokines (Weiss et al, 1987 (Kirkman et al, 1985) and a high IL-2 can terminate pregnancy in mice (Lala et al, 1990 ), IL-2 may play an integral role in allograft acceptance. Results from many studies have indicated that a relationship exists between conceptus or uterine derived suppressor factors and IL-2 production (Segerson, 1988; Saito et al, 1990; Segerson & Gunsett, 1990; Segerson & Libby, 1990) . We tested the hypoth¬ esis that the suppressive mechanism of HCS is mediated through the inhibition of IL-2 production. Our initial attempt to overcome a potential deficiency of IL-2 in HCS-treated cultures, by sup¬ plementing the cultures with peripheral blood lymphocyte supernatant, was not particularly effective. Since it has been shown that stimulated equine lymphocyte supernatant contains the lymphokines required to stimulate IL-2-dependent cell responses (Magnuson et (Fig. 3 ) remained constant at all levels of rIL-2 indicating that, while the effect of rIL-2 was similar in both treatments, there were fewer cells that could respond to the rIL-2 in the phytohaemagglutinin + HCS cultures. Because a suboptimal dose of phyto¬ haemagglutinin was used in the cultures, there was an IL-2 deficiency and the enhanced prolifer¬ ation observed in the rIL-2-supplemented cultures simply reflected the effect of sufficient IL-2 on those cells not suppressed by HCS. One explanation for the inability of rIL-2 to overcome HCSinduced suppression is that HCS inhibits IL-2R activation; alternatively, HCS may be interfering with the necessary interactions between IL-2 and IL-2R.
The latter hypothesis was tested using CTLL-2 cells that continuously express the high-affinity IL-2R. While the Mr < 100 000 fraction of HCS inhibited CTLL-2 cell proliferation, possibly owing to hormones or interferons produced by the horse conceptus or both, the Mr > 100 000 fraction containing HCS exerted no suppressive effect on the CTLL-2 cell response to rIL-2. The fact that murine splenocytes are suppressed if treated with the same concentration of the Mr > 100 000 fraction of HCS indicates that the ineffectiveness of HCS on CTLL-2 cells is not simply due to species specificity of the suppressor factor. These results suggest that HCS interferes with cellular events before the expression of the high-affinity IL-2R, but cannot suppress cell pro¬ liferation after IL-2R expression. However, it is possible that the CTLL-2 cells differ significantly from cells found in vivo, and thus may not be vulnerable to the suppressor activity of HCS.
Together, the results from rIL-2 supplementation ( Fig. 3 and Table 2 ) suggest that, in cultures treated with HCS, there are fewer IL-2R-expressing cells that can respond to rIL-2 than in controls. These results are in agreement with reports by Bulmer & Johnson (1986) who found that cells in human decidua do not express IL-2Rs. It is not known whether IL-2R expression is inhibited by HCS directly or indirectly through the interference of HCS with other early events in T-cell activation. For example, suppression may result from an alteration in the production or function of IL-1. Such a mechanism of suppression has been suggested for a human placental protein (Pockley &Bolton, 1990 ).
We reported the production of an immunosuppressive factor produced by day 10 to day 26 horse conceptuses (Roth et al, 1990) . In that study, the conceptus cultures were performed as described here for obtaining HCS 1. In this study, we cultured day 20 conceptuses in medium without FCS, thereby obtaining HCS 2. The immunosuppressive characteristics of HCS 1 and 2 appear to be similar, indicating that supplementation of FCS to the culture medium is not required by horse conceptus tissue for the production of the suppressor factor. HCS has an > 100 000, suppresses proliferation of cells and seems to suppress lymphocytes indirectly. This noncytotoxic suppressor factor is effective only if present during the early stages of lymphocyte acti¬ vation and its effect on cells is reversible. HCS suppression is highly dependent on its presence during the early stages of cell activation and could explain why the suppressive factors are produced as early as day 10 of pregnancy (Roth et al, 1990 ). Our results suggest that the factor(s) suppress cell proliferation by preventing IL-2R activation. In view of the fact that cells are largely responsible for allograft rejection, and the interaction between IL-2 and IL-2R is a prerequisite for complete T-cell activation, we hypothesize that this suppressor factor disrupts the T-cell-mediated allograft rejection that might otherwise terminate pregnancy by inhibiting IL-2R function.
